4//SEC Filing
Petersen Floyd F. 4
Accession 0001415889-25-011878
CIK 0001297184other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 8:27 PM ET
Size
5.2 KB
Accession
0001415889-25-011878
Insider Transaction Report
Form 4
Petersen Floyd F.
Director
Transactions
- Sale
Common Stock
2025-05-01$24.08/sh−500$12,041→ 73,409 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.785 to $24.325, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Amphastar Pharmaceuticals, Inc.
CIK 0001297184
Entity typeother
Related Parties
1- filerCIK 0001611286
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 8:27 PM ET
- Size
- 5.2 KB